A Framework for Assessing the Opportunity for Advanced Research, Development, and Regulatory Approval of Medical Countermeasures: A Component of BARDA's Emerging Infectious Diseases Strategy

• by Richard C White, Rachael G Lewis, James D Little, Brenda L Fredericksen, Carol L Sabourin, M Chelsea Lane, Shannon G Loelius, Kimberly A Hofmeyer, Matthew Steele, Xiaomi Tong, Robert A Johnson

• October 9, 2025

Medical Oddities: Disney, But Make It Clinical

From princess pathology to ICU dental cases—this lineup escalates quickly.

• by Teraya Smith

• April 16, 2026

• 6 min

FDA Reshapes Drug Testing Approach

The agency outlined early regulatory actions supporting nonanimal methods, including draft guidance, artificial intelligence tools, and expanded use of human-relevant data models.

• by Kathryn Wighton

• April 20, 2026

• 2 min

The 18-Month MDR-TB Regimen Has a Successor

Six months, all-oral, better tolerated—and the infrastructure to make it work.

• by Kerri Miller

• April 16, 2026

• 3 min